| Specialty: |
- Medical Oncology
- Hematology
- Internal Medicine
|
| Board Certification: |
- Internal Medicine
- Hematology
- Medical Oncology
|
| Faculty Rank: |
Assistant Professor |
|
Medical or Graduate Education:
|
University of Cincinnati College of Medicine
|
|
Residency:
|
Ohio State University Medical Center - Internal Medicine
|
|
Fellowship:
|
McGaw Medical Center of Northwestern University - Hematology/Oncology
|
| Clinical Expertise: |
- Gastrointestinal cancers
- Pancreatic cancer
|
| Research Interests: |
- Pancreatic cancer
- Primary and metastatic cancer of the liver
|
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
- A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.
Hill ME, Li X, Kim S, Campbell A, Culler K, Bloomston M, Zalupski M, Hejna G, Bekaii-Saab T.
Cancer Chemother Pharmacol.
2011 Mar
67(3):511-7
- A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies.
Bekaii-Saab T, Hill M, Campbell A, Kosuri K, Thomas J, Villalona-Calero M.
Cancer Chemother Pharmacol.
2010 Apr
65(5):863-9